Active Thyroid Cancer Specific Trials
For available solid tumor basket trials please e-mail us at scthycc@labiomed.org or call 310-222-8172.
1) A Phase 3 Trial Comparing Loxo-292 to Physicians Choice of Cabozantinib or Vandetanib in Patients with Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)- Link to come soon.
6) Phase I Study of BLU-667 (highly selective RET inhibitor) for MTC and PTC
8) Phase II Clinical Trial for Tipifarnib for HRAS-mutant Thyroid Cancer
9) Active Surveillance of Papillary Thyroid Microcarcinoma